February 2024

Vancouver, British Columbia and Rehovot, Israel – February 26, 2024 – BioHarvest Sciences Inc., (CSE: BHSC) (OTCQB: CNVCF) (FSE: 8MV) (“BioHarvest” or “the Company”), a biotechnology company pioneering the Botanical Synthesis process technology, has announced the official launch of its new Contract Development and Manufacturing Organization (CDMO) business unit. The Company is also announcing that

Vancouver, British Columbia and Rehovot, Israel – February 15, 2024 – BioHarvest Sciences Inc., (CSE: BHSC) (OTCQB: CNVCF) (FSE: 8MV) (“BioHarvest” or “the Company”), a biotechnology company pioneering botanical synthesis, has engaged investor relations specialists MZ Group (MZ) to lead a strategic investor relations and financial communications program across all key markets. MZ will work

Vancouver, British Columbia and Rehovot, Israel – February 12, 2024 – BioHarvest Sciences Inc., (CSE: BHSC) (OTCQB: CNVCF) (FSE: 8MV) (“BioHarvest” or “the Company”), a pioneer in Botanical Synthesis technology that grows Phyto-active compositions without growing the plant, announces its upcoming participation and title sponsorship of  the 2024 BIO CEO & Investor Conference, which will